Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209384) titled 'Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Junpeng Wang
Condition:
Unresectable Colorectal Cancer
Advanced Malignancy
Elderly (People Aged 65 or More)
Intervention:
Procedure: Transarterial chemoembolization
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 1, 2025
Target Sample Size: 50
To know more, vi...